United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 2, 2026

On Jun 1, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$547.91 for US$5.21M under a trading plan, leaving 40,513 shares. Filed Jun 2, 2026 (Form 4).

Sold
9,500 shares
Price
US$547.91 average (US$545.04 to US$554.43)
Value
US$5.21M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 1, 2026Common StockSale1,365US$545.0448,648Direct
Jun 1, 2026Common StockSale2,213US$546.2146,435Direct
Jun 1, 2026Common StockSale1,376US$547.1145,059Direct
Jun 1, 2026Common StockSale1,546US$548.2143,513Direct
Jun 1, 2026Common StockSale1,166US$549.3142,347Direct
Jun 1, 2026Common StockSale1,070US$550.2641,277Direct
Jun 1, 2026Common StockSale124US$550.8241,153Direct
Jun 1, 2026Common StockSale240US$552.8240,913Direct
Jun 1, 2026Common StockSale400US$554.4340,513Direct

Source

View original at SEC

Related